News - Oragenics Inc.
2007-12-05 12:00:44
Oragenics, Inc. (AMEX: ONI), a biotechnology development company focused on infectious diseases and cancer, announced today that Qualia Clinical Services, located in Omaha, Nebraska, has been selected to provide clinical site services for the Company's recently approved Phase 1b safety trial.
2007-10-31 15:00:42
Oragenics, Inc. (AMEX: ONI) announced today that it has received notification from the U.S.